Hyperhomocysteinemia in patients with pulmonary embolism is associated with impaired plasma fibrinolytic capacity

Journal of Thrombosis and Thrombolysis

Volumn 38, Issue 1, 2014, Pages 45-49

  Cellai, Anna Paola ^a   Lami, Donatella ^b   Antonucci, Emilia ^b   Liotta, Agatina Alessandrello ^a   Rogolino, Angela ^a   Fedi, Sandra ^b   Fiorillo, Claudia ^b   Becatti, Matteo ^b   Cenci, Caterina ^b   Marcucci, Rossella ^b   Abbate, Rosanna ^b   Prisco, Domenico ^b  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Clot lysis time; Homocysteine; Pulmonary embolism; Thrombin activatable fibrinolysis inhibitor

Indexed keywords

FIBRIN; HOMOCYSTEINE; PLASMIN; THROMBOPLASTIN; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; BETA CHAIN; BODY MASS; CONTROLLED STUDY; DISEASE ASSOCIATION; EUGLOBULIN LYSIS TEST; FEMALE; FIBRIN CLOT; FIBRINOLYSIS; HIGH RISK PATIENT; HUMAN; HYPERHOMOCYSTEINEMIA; IMMUNOASSAY; IN VITRO STUDY; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; RISK ASSESSMENT; RISK FACTOR; VERY ELDERLY; YOUNG ADULT; BLOOD; CLINICAL TRIAL; COMPLICATION; METABOLISM; MIDDLE AGED;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FIBRIN; FIBRINOLYSIN; FIBRINOLYSIS; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; MIDDLE AGED; PROTEOLYSIS; PULMONARY EMBOLISM; RISK FACTORS;

EID: 84902365340     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-013-0981-1     Document Type: Article

References (20)

1. Lisman T, de Groot PG, Meijers JC, Rosendaal FR (2005) Reduced plasma fibrinolytic potential is a risk factor for venous thrombosis. Blood 105:1102-1105 (Pubitemid 40170881)
2. Guimarães AH, de Bruijne EL, Lisman T, Dippel DW, Deckers JW, Poldermans D, Rijken DC, Leebeek FW (2009) Hypofibrinolysis is a risk factor for arterial thrombosis at young age. Br J Haematol 145:115-120
3. Meltzer ME, Doggen CJ, de Groot PG, Rosendaal FR, Lisman T (2007) Fibrinolysis and the risk of venous and arterial thrombosis. Curr Opin Hematol 14:242-248 (Pubitemid 46597610)
4. Cellai AP, Lami D, Fedi S, Marcucci R, Mannini L, Cenci C, Rogolino A, Sodi A, Menchini U, Abbate R, Prisco D (2012) A hypercoagulable and hypofibrinolytic state is detectable by global methods in patients with retinal vein occlusion. Atherosclerosis 224:97-101
5. Grifoni E, Marcucci R, Ciuti G, Cenci C, Poli D, Mannini L, Liotta AA, Miniati M, Abbate R, Prisco D (2012) The thrombophilic pattern of different clinical manifestations of venous thromboembolism: a survey of 443 cases of venous thromboembolism. Semin Thromb Hemost 38:230-234
6. Naess IA, Christiansen SC, Romundstad PR, Cannegieter SC, Blom HJ, Rosendaal FR, Hammerstrøm J (2008) Prospective study of homocysteine and MTHFR 677TT genotype and risk for venous thrombosis in a general population-results from the HUNT 2 study. Br J Haematol 141:529-535 (Pubitemid 351550558)
7. Bezemer ID, Doggen CJ, Vos HL, Rosendaal FR (2007) No association between the common MTHFR 677C->T polymorphism and venous thrombosis: results from the MEGA study. Arch Intern Med 167:497-501 (Pubitemid 46425663)
8. Durga J, Verhoef P, Anteunis LJ, Schouten E, Kok FJ (2007) Effects of folic acid supplementation on hearing in older adults: a randomized, controlled trial. Ann Intern Med 146:1-9 (Pubitemid 351650315)
9. Kołodziejczyk J, Malinowska J, Nowak P, Olas B (2010) Comparison of the effect of homocysteine and its thiolactone on the fibrinolytic system using human plasma and purified plasminogen. Mol Cell Biochem 344:217-220
10. Undas A, Brozek J, Jankowski M, Siudak Z, Szczeklik A, Jakubowski H (2006) Plasma homocysteine affects fibrin clot permeability and resistance to lysis in human subjects. Arterioscler Thromb Vasc Biol 26:1397-1404 (Pubitemid 44305388)
11. Colucci M, Cattaneo M, Martinelli I, Semeraro F, Binetti BM, Semeraro N (2008) Mild hyperhomocysteinemia is associated with increased TAFI levels and reduced plasma fibrinolytic potential. J Thromb Haemost 6:1571-1577
12. Cellai AP, Lami D, Antonucci E, Fiorillo C, Becatti M, Olimpieri B, Bani D, Grifoni E, Cenci C, Marcucci R, Mannini L, Poli D, Abbate R, Prisco D (2013) Fibrinolytic inhibitors and fibrin characteristics determine a hypofibrinolytic state in patients with pulmonary embolism. Thromb Haemost 109:565-567
13. Miniati M, Fiorillo C, Becatti M, Monti S, Bottai M, Marini C, Grifoni E, Formichi B, Bauleo C, Arcangeli C, Poli D, Nassi PA, Abbate R, Prisco D (2010) Fibrin resistance to lysis in patients with pulmonary hypertension other than thromboembolic. Am J Respir Crit Care Med 181:992-996
14. Galiè N, Torbicki A, Barst R, Dartevelle P, Haworth S, Higenbottam T, Olschewski H, Peacock A, Pietra G, Rubin LJ, Simonneau G, Priori SG, Garcia MA, Blanc JJ, Budaj A, Cowie M, Dean V, Deckers J, Burgos EF, Lekakis J, Lindahl B, Mazzotta G, McGregor K, Morais J, Oto A, Smiseth OA, Barbera JA, Gibbs S, Hoeper M, Humbert M, Naeije R, Pepke-Zaba J, Task Force (2004) Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The task force on diagnosis and treatment of pulmonary arterial hypertension of the European Society of Cardiology. Eur Heart J 25:2243-2278
15. Cellai AP, Lami D, Magi A, Liotta AA, Rogolino A, Antonucci E, Bandinelli B, Abbate R, Prisco D (2010) Assessment of fibrinolytic activity by measuring the lysis time of a tissue-factor-induced clot: a feasibility evaluation. Clin Appl Thromb Hemost 16:337-344
16. Lisman T, Leebeek FW, Mosnier LO, Bouma BN, Meijers JC, Janssen HL, Nieuwenhuis HK, De Groot PG (2001) Thrombin activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis. Gastroenterology 121:131-139 (Pubitemid 32591523)
17. Buckell M (1958) The effect of citrate on euglobulin methods of estimating fibrinolytic activity. J Clin Pathol 11:403-405
18. Ranucci M, Ballotta A, Frigiola A, Boncilli A, Brozzi S, Costa E, Mehta RH (2009) Pre-operative homocysteine levels and morbidity and mortality following cardiac surgery. Eur Heart J 30:995-1004
19. Meltzer ME, Lisman T, de Groot PG, Meijers JC, le Cessie S, Doggen CJ, Rosendaal FR (2010) Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1. Blood 116:113-121
20. Morris TA, Marsh JJ, Chiles PG, Auger WR, Fedullo PF, Woods VL (2006) Fibrin derived from patients with chronic thromboembolic pulmonary hypertension is resistant to lysis. Am J Respir Crit Care Med 173:1270-1275 (Pubitemid 43848399)